Mostrar el registro sencillo del documento

Implementación de tratamientos de Braquiterapia volumétrica para cáncer de cuello uterino en un hospital público de mediana y alta complejidad del suroccidente colombiano, 2022

dc.rights.licenseReconocimiento 4.0 Internacional
dc.contributor.advisorOrejuela Mosquera, Diego Mauricio
dc.contributor.authorMontenegro Moreno, Giselle Alejandra
dc.coverage.temporal2022
dc.date.accessioned2023-04-19T16:08:31Z
dc.date.available2023-04-19T16:08:31Z
dc.date.issued2022-12-19
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/83736
dc.descriptionilustraciones, fotografías a color
dc.description.abstractEn el presente trabajo se presenta la implementación de tratamiento de braquiterapia ginecológica intracavitaria de alta tasa de dosis (HDR) con aplicador Fletcher. El documento se estructura en dos ejes de gran impacto como son: 1) El control de calidad del equipo de braquiterapia y 2) el análisis dosimétrico entre dos tipos de planeaciones: una técnica de prescripción a puntos A y otra con prescripción al volumen clínico objetivo CTV contorneado por el médico radioncólogo. Se llevaron a cabo pruebas al equipo de carga diferida remota BRAVOS con el fin de dar cumplimiento al sistema de seguridad del HDR antes de iniciar un tratamiento, las pruebas del conjunto dosimétrico y la tasa de referencia de Kerma en aire para cada cambio de fuente. Con el fin de realizar el análisis dosimétrico, se hizo una comparación entre los parámetros de la planeación coon prescripción a puntos A con los parámetros de la planeación volumétrica y adicionalmente, se realizó una comparación cruzada, es decir, se evaluaron los parámetros de la planeación volumétrica en la planeación de puntos A para analizar las diferencias de dosis. Los resultados de este trabajo indican el cumplimiento del control de calidad del equipo BRAVOS y adicionalmente, muestra las diferencias dosimétricas entre los dos tipos de planeación. (Texto completo)
dc.description.abstractThis paper presents the implementation of high dose rate (HDR) intracavitary gynecological brachytherapy treatment with a Fletcher applicator. The document has two sections that leave an impact on the study: 1) Quality control of the brachytherapy equipment and 2) Dosimetric analysis between two types of planning: a prescription technique to points A and another with a prescription to the target clinical volume. CTV is contoured by the radiation oncologist's doctor. Using remote afterloading equipment BRAVOS, different tests were carried out to comply with the HDR security system before starting treatment, the tests of the dosimetric set, and for each source change, the reference rate of Kerma in the air. In order to carry out the dosimetric analysis, a comparison was made between the planning parameters with prescription at points A with the volumetric planning parameters and additionally, a cross-comparison was made, which means that the volumetric planning parameters were evaluated in the planning of points A to analyze the differences in dose. The results showed compliance with the quality control of the BRAVOS team and also shows the dosimetric differences between the two types of planning.
dc.format.extentviii, 71 páginas
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.publisherUniversidad Nacional de Colombia
dc.publisherHospital Universitario del Valle
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.ddc530 - Física::535 - Luz y radiación relacionada
dc.titleImplementación de tratamientos de Braquiterapia volumétrica para cáncer de cuello uterino en un hospital público de mediana y alta complejidad del suroccidente colombiano, 2022
dc.typeTrabajo de grado - Maestría
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.versioninfo:eu-repo/semantics/acceptedVersion
dc.publisher.programBogotá - Ciencias - Maestría en Física Médica
dc.contributor.refereeSalcedo Suarez, Diana Carolina
dc.contributor.refereePinilla Beltrán, Edna Carolina
dc.contributor.supervisorPlazas, María Cristina
dc.coverage.countryColombia
dc.description.degreelevelMaestría
dc.description.degreenameMagíster en Física Médica
dc.description.researchareaRadioterapia
dc.identifier.instnameUniversidad Nacional de Colombia
dc.identifier.reponameRepositorio Institucional Universidad Nacional de Colombia
dc.identifier.repourlhttps://repositorio.unal.edu.co/
dc.publisher.facultyFacultad de Ciencias
dc.publisher.placeBogotá,Colombia
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotá
dc.relation.references[1] H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray, “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians, vol. 71, pp. 209–249, May 2021
dc.relation.references[2] L. Bruni, G. Albero, B. Serrano, M. Mena, J. Collado, D. Gómez, J. Muñoz, F. Bosch, and S. de San José, “Human Papillomavirus and Related Diseases in Colombia,” ICO IARC Information Centre on HPV and Cancer (HPV Information Centre, vol. Summary Report 22 October 2021, 2021.
dc.relation.references[3] K. Han, M. Milosevic, A. Fyles, M. Pintilie, and A. N. Viswanathan, “Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States”, International Journal of Radiation Oncology Biology Physics, vol. 87, pp. 111–119, Sept. 2013
dc.relation.references[4] P. Georg, S. Lang, J. C. Dimopoulos, W. D¨orr, A. E. Sturdza, D. Berger, D. Georg, C. Kirisits, and R. P¨otter, “Dose–Volume Histogram Parameters and Late Side Effects in Magnetic Resonance Image–Guided Adaptive Cervical Cancer Brachytherapy,” International Journal of Radiation Oncology*Biology*Physics, vol. 79, pp. 356–362, Feb. 2011
dc.relation.references[5] R. Pötter, P. Georg, J. C. Dimopoulos, M. Grimm, D. Berger, N. Nesvacil, D. Georg, M. P. Schmid, A. Reinthaller, A. Sturdza, and C. Kirisits, “Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer,” Radiotherapy and Oncology, vol. 100, pp. 116–123, July 2011
dc.relation.references[6] M. C. Tod and W. J. Meredith, “A Dosage System for Use in the Treatment of Cancer of the Uterine Cervix,” The British Journal of Radiology, vol. 11, pp. 809–824, Dec.1938
dc.relation.references[7] A. N. Viswanathan and B. Thomadsen, “American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: General principles,” Brachytherapy, vol. 11, pp. 33–46, Jan. 2012
dc.relation.references[8] C. Haie-Meder, R. Pötter, E. Van Limbergen, E. Briot, M. De Brabandere, J. Dimopoulos, I. Dumas, T. P. Hellebust, C. Kirisits, S. Lang, S. Muschitz, J. Nevinson, A. Nulens, P. Petrow, and N. Wachter-Gerstner, “Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV,” Radiotherapy and Oncology, vol. 74, pp. 235–245, Mar. 2005
dc.relation.references[9] R. Pötter, C. Haie-Meder, E. V. Limbergen, I. Barillot, M. D. Brabandere, J. Dimopoulos, I. Dumas, B. Erickson, S. Lang, A. Nulens, P. Petrow, J. Rownd, and C. Kirisits, “Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology,” Radiotherapy and Oncology, vol. 78, pp. 67–77, Jan. 2006
dc.relation.references[10] M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. Saiful Huq, G. S. Ibbott, M. G. Mitch, R. Nath, and J. F. Williamson, “Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations,” Medical Physics, vol. 31, pp. 633–674, Feb. 2004
dc.relation.references[11] ICRU, Dose and volume specification for reporting intracavitary therapy in gynecology. No. 38 in ICRU report, Bethesda, Md., U.S.A: International Commission on Radiological Units and Measurements, 1985
dc.relation.references[12] M. Holmgren, “Brachytherapy for cancer of the cervix. 3D Dose distributions for new ring applicator using BrachyVision, for clinical useBrachytherapy for cancer of the cervix. 3D Dose distributions for new ring applicator using BrachyVision, for clinical use,” 2005
dc.relation.references[13] A. Camacho, C. Beltran, A. Ramon, and A. Luis, “Criterios de Evaluación en Planes de Tratamiento de Braquiterapia Intracavitaria Tridimensional HDR,” Asociación Colombiana de Radioterapia Oncológica, vol. 10, 2013
dc.relation.references[14] A. Brosed, Fundamentos de fisica médica. Madrid: Aula Documental de Investigación, 2011. OCLC: 908606357
dc.relation.references[15] B.-A. Jönsson, “Henri Becquerel’s discovery of radioactivity – 125 years later,” Physica Medica, vol. 87, pp. 144–146, July 2021
dc.relation.references[16] G. Kemikler, “History of Brachytherapy,” Turkish Journal of Oncology, 2019
dc.relation.references[17] R. N. , et al. “Dosimetry of interstitial brachytherapy sources: Recommendations of the aapm radiation therapy committee task group no. 43,” Med. Phys, vol. 22, pp. 209–34, 1995
dc.relation.references[18] R. N. , et al. “Code of practice for brachytherapy physics: Report of the aapm radiation therapy committee task group no. 56,” Med. Phys, vol. 24, pp. 1557–98, 1997
dc.relation.references[19] H. K. , et al. “High dose-rate brachytherapy treatment delivery: Report of the aapm radiation therapy committee task group no. 59,” Med. Phys, vol. 25, pp. 375–403, 1998(a)
dc.relation.references[20] “Calibration of brachytherapy sources.guidelines to secondary standard dosimetry laboratories (ssdls) and medical physicists on standardized methods for calibration of brachytherapy sources.,”
dc.relation.references[21] International Atomic Energy Agency, Lessons learned from accidental exposures in radiotherapy. 2000
dc.relation.references[22] “Calibración, matrices de dosis y control de calidad en braquiterapia: informe del grupo de trabajo de braquiterapia de la sefm,”
dc.relation.references[23] IAEA, “Aspectos físicos de la garantía de calidad en radioterapia: Protocolo de control de calidad IAEA-TECDOC-1151,” International Atomic Energy Agency, 2020
dc.relation.references[24] IAEA, “Calibración de fuentes de fotones y rayos beta usadas en braquiterapia: IAEA TECDOC- 1274/S,” International Atomic Energy Agency, 2004
dc.relation.references[25] U. Mahantshetty, S. Gudi, R. Singh, A. Sasidharan, S. C. Sastri, L. Gurram, D. Sharma, S. Ganeshrajah, J. Mg, D. Badakh, A. Basu, F. James, J. Swamidas, T. Kuppuswamy, and R. Bhalavat, “Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy,” Journal of Contemporary Brachytherapy, vol. 11, no. 4, pp. 293–306, 2019
dc.relation.references[26] U. Mahantshetty, R. Poetter, S. Beriwal, S. Grover, G. Lavanya, B. Rai, P. Petric, K. Tanderup, H. Carvalho, N. Hegazy, S. Mohamed, T. Ohno, and N. Amornwichet, “IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer,” Radiotherapy and Oncology, vol. 160, pp. 273–284, July 2021
dc.relation.references[27] NCI, “NCI Dictionaries, National Cancer Institute,” Feb. 2011. Archive Location: nciglobal, ncienterprise
dc.relation.references[28] T. Winslow, “Terese Winslow LLC, Medical and Scientific Illustration.”
dc.relation.references[29] N. Bhatla, D. Aoki, D. N. Sharma, and R. Sankaranarayanan, “Cancer of the cervix uteri,” International Journal of Gynecology & Obstetrics, vol. 143, pp. 22–36, Oct. 2018
dc.relation.references[30] N. Bhatla, D. Aoki, D. N. Sharma, and R. Sankaranarayanan, “Cancer of the cervix uteri: 2021 update,” International Journal of Gynecology & Obstetrics, vol. 155, pp. 28– 44, Oct. 2021
dc.relation.references[31] OPS, “Clasificación estadística internacional de enfermedades y problemas relacionados con la salud,” Organización Panamericana de la Salud, vol. 1, 2008
dc.relation.references[32] IAEA, Implementation of high dose rate brachytherapy in limited resource settings. International Atomic Energy Agency, 2015. OCLC: 913058359
dc.relation.references[33] M. Straughn and C. M. Yashar, “Management of locally advanced cervical cancer,” 2017
dc.relation.references[34] Varian, “A brave new world in brachytherapy: Applicators & Accessories,” Varian Medical Systems, 2020
dc.relation.references[35] Varian, “Instrucciones de uso de BRAVOS™,” Varian Medical Systems, 2020
dc.relation.references[36] N. R. Datta, A. Srivastava, K. J. Maria Das, A. Gupta, and N. Rastogi, “Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer,” Brachytherapy, vol. 5, pp. 223–229, Oct. 2006
dc.relation.references[37] S. L. Schoeppel, M. L. Lavigne, M. K. Martel, D. L. McShan, B. A. Fraass, and J. A. Roberts, “Three-dimensional treatment planning of intracavitary gynecologic implants: Analysis of ten cases and implications for dose specification,” International Journal of Radiation Oncology*Biology*Physics, vol. 28, pp. 277–283, Jan. 1994
dc.relation.references[38] P. Georg, S. Lang, J. C. Dimopoulos, W. D¨orr, A. E. Sturdza, D. Berger, D. Georg, C. Kirisits, and R. P¨otter, “Dose–Volume Histogram Parameters and Late Side Effects in Magnetic Resonance Image–Guided Adaptive Cervical Cancer Brachytherapy,” International Journal of Radiation Oncology*Biology*Physics, vol. 79, pp. 356–362, Feb. 2011
dc.relation.references[39] R. N. Eskander, D. Scanderbeg, C. C. Saenz, M. Brown, and C. Yashar, “Comparison of Computed Tomography and Magnetic Resonance Imaging in Cervical Cancer Brachytherapy Target and Normal Tissue Contouring”, International Journal of Gynecological Cancer, vol. 20, pp. 47–53, Jan. 2010
dc.relation.references[40] J. L. Forrest, I. Ackerman, L. Barbera, E. A. Barnes, M. Davidson, A. Kiss, and G. Thomas, “Patient Outcome Study of Concurrent Chemoradiation, External Beam Radiotherapy, and High-Dose Rate Brachytherapy in Locally Advanced Carcinoma of the Cervix,” International Journal of Gynecologic Cancer, vol. 20, pp. 1074–1078, July 2010
dc.relation.references[41] J. C. Dimopoulos, R. Pötter, S. Lang, E. Fidarova, P. Georg, W. Dörr, and C. Kirisits, “Dose–effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy,” Radiotherapy and Oncology, vol. 93, pp. 311–315, Nov. 2009
dc.relation.references[42] F. D. Patel, P. Kumar, G. Karunanidhi, S. C. Sharma, and R. Kapoor, “Optimization of high–dose-rate intracavitary brachytherapy schedule in the treatment of carcinoma of the cervix,” Brachytherapy, vol. 10, pp. 147–153, Mar. 2011
dc.relation.references[43] E. Podgorsak, “Radiation oncology physics: A handbook for teachers and students,” International Atomic Energy Agency, 2005
dc.relation.references[44] G. J. Kutcher, L. Coia, M. Gillin, W. F. Hanson, S. Leibel, R. J. Morton, J. R. Palta, J. A. Purdy, L. E. Reinstein, G. K. Svensson, M. Weller, and L. Wingfield, “Comprehensive QA for radiation oncology: Report of AAPM Radiation Therapy Committee Task Group 40,” Medical Physics, vol. 21, pp. 581–618, Apr. 1994
dc.relation.references[45] HUV, “Reseña histórica huv,” Hospital Universitario del Valle, 2022
dc.relation.references[46] I. T. Castro, “Plan operativo anual institucional- vigencia 2022,” Hospital Universitario del Valle, 2022
dc.relation.references[47] MinMinas, “Decreto Ley 4131 DEL 3 de Noviembre de 2011,” Ministerio de Minas y Energía, 2011
dc.relation.references[48] SGC, “Decreto 2703 DE 2013,” Consejo Directivo del Servicio Geológico Colombiano (SGC), 2013
dc.relation.references[49] MinMinas, “Resolución 90698 DE 2014,” Ministerio de Minas y Energía, 2014
dc.relation.references[50] MinMinas, “Resolución 40569 DE 2019,” Ministerio de Minas y Energía, 2019
dc.relation.references[51] MinMinas, “Resolución 41226 DE 2016,” Ministerio de Minas y Energía, 2016
dc.relation.references[52] MinMinas, “Resolución DAN-1213 DEL 6 de mayo de 2022,” Ministerio de Minas y Energía, 2022
dc.relation.references[53] MinMinas, “Resolución 181682 DE 2005,” Ministerio de Minas y Energía, 2005
dc.relation.references[54] MinMinas, “Resolución 180005 DE 2010,” Ministerio de Minas y Energía, 2010
dc.relation.references[55] MinMinas, “Resolución 181434 DE 2002,” Ministerio de Minas y Energía, 2002
dc.relation.references[56] MinSalud, “Decreto Número 4725 DE 2005,” Ministerio de la Protección Social, 2005
dc.relation.references[57] MinSalud, “Resolución Número 1328 DE 2021,” Ministerio de Salud y Protección Social, 2021
dc.relation.references[58] P. Andreo, D. T. Burns, A. E. Nahum, J. Seuntjens, and F. H. Attix, Fundamentals of ionizing radiation dosimetry. Textbook / Pedro Andreo, David T. Burns, Alan E. Nahum, Jan Seuntjens, and Frank H. Attix. Weinheim: Wiley-VCH, 2017
dc.relation.references[59] D. Baltas, N. Zamboglou, and L. Sakelliou, The physics of modern brachytherapy for oncology. Series in medical physics and biomedical engineering, Boca Raton: Taylor & Francis, 2007. OCLC: ocm64335913
dc.relation.references[60] MinSalud, “Resolución Número 8430 DE 1993,” Ministerio de Salud y Protección Social, 1993
dc.relation.references[61] Determinacion de la dosis absorbida en radioterapia con haces externos: un codigo de Practical Internacional para la dosimetria basada en patrones de dosis absorbida en agua. Vienna: International Atomic Energy Agency, 2005. OCLC: 1085579646
dc.relation.references[62] SGSSS, Situación del cáncer en la población adulta atendida en el SGSSS de Colombia. Bogotá D.C.: Fondo Colombiano de Enfermedades de Alto Costo, Cuenta de Alto Costo (CAC), 2021
dc.relation.references[63] S. C. Chacón-Anaya, M. Durán-Cruz, A. Reding-Bernal, and J. A. Barragán-Pérez, “Dosimetric analysis between Mánchester points,” Gaceta Mexicana de Oncología, vol. 20, p. 5366, June 2021
dc.relation.references[64] K. Derks, J. L. Steenhuijsen, H. A. v. d. Berg, S. Houterman, J. Cnossen, P. v. Haaren, and K. D. Jaeger, “Impact of brachytherapy technique (2D versus 3D) on outcome following radiotherapy of cervical cancer,” Journal of Contemporary Brachytherapy, vol. 10, no. 1, pp. 17–25, 2018
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.subject.decsTratamiento
dc.subject.decsTreatment
dc.subject.decsCuello del útero
dc.subject.decsCervix Uteri
dc.subject.decsRadioterapia
dc.subject.decsRadiotherapy
dc.subject.proposalBraquiterapia intracavitaria
dc.subject.proposalAplicador Fletcher
dc.subject.proposalControl de calidad
dc.subject.proposalAnálisis dosimétrico
dc.subject.proposalIntracavitary brachytherapy
dc.subject.proposalFletcher applicator
dc.subject.proposalQuality control
dc.subject.proposalDosimetric analysis
dc.title.translatedVolumetric brachytherapy treatments implementation for cervical cancer in a public hospital in southwestern Colombia, 2022
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.contentText
dc.type.redcolhttp://purl.org/redcol/resource_type/TM
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2
dcterms.audience.professionaldevelopmentPúblico general
dc.contributor.orcidMontenegro Moreno, Giselle [0000-0003-4932-9096]
dc.contributor.cvlacMontenegro Moreno, Giselle


Archivos en el documento

Thumbnail
Nombre:
1053863172.2022.pdf
Tamaño:
7.883Mb
Formato:
PDF
Descripción:
Tesis de Maestría en Braquiterapia ...
Descargar

Este documento aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del documento

Reconocimiento 4.0 InternacionalEsta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial 4.0.Este documento ha sido depositado por parte de el(los) autor(es) bajo la siguiente constancia de depósito